Matthew R Plooster

ZVRA

Matthew R Plooster serves as Director at Zevra Therapeutics, Inc. (ZVRA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$70.9K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$70.9K

Companies Traded

ZVRA

Active Period

May 2022 – Mar 2023

2 total trades

Most Recent

Buy ZVRA

Mar 13, 2023 · $46.1K

Matthew R Plooster's Insider Trading at Zevra Therapeutics, Inc. (ZVRA)

Buys

2 · $70.9K

Sells

0 · $0.00

Total Shares Bought

16,000

Total Shares Sold

ZVRA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 13, 2023	Buy	11,000	$4.20	$46.1K	18,500
May 18, 2022	Buy	5,000	$4.96	$24.8K	7,500

Related Insiders

Neil F. McFarlane

President and CEO

ZVRASell · Feb 10, 2026

Joshua Schafer

officer: CCO

ZVRASell · Feb 4, 2026

Timothy J. Sangiovanni

SVP, Finance & Corp Controller

ZVRASell · Feb 4, 2026

Rahsaan Thompson

officer, other: Chief Legal & Compliance

ZVRASell · Feb 2, 2026

Adrian W Quartel

officer: Chief Medical Officer

ZVRASell · Feb 2, 2026

R. LaDuane Clifton

Insider

ZVRASell · Dec 31, 2025

FAVORITO TAMARA A

Director

ZVRABuy · Sep 12, 2025

Alvin Shih

Director

ZVRABuy · Sep 12, 2025

Explore More Insider Trading Data

ZVRA Insider Trading Activity

View all insider trades at Zevra Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity